The symptoms of a possible overdose may include palpitations, changes in alertness level (ranging from drowsiness to coma) blurred vision, convulsions or seizures and vomiting.
If you have not taken a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and take only one dose as usual. Do not take a double dose to compensate for the missed doses. Do not take more than the daily dose of Vandral Retard that you have been prescribed in a day.
Do not stop taking your treatment or reduce the dose without consulting your doctor, even if you feel better. If your doctor thinks you no longer need Vandral Retard, they may ask you to gradually reduce the dose before stopping treatment completely. It is known that adverse effects occur when people stop using this medication, especially when it is stopped suddenly or if the dose is reduced very quickly. Some patients may experience symptoms such as suicidal thoughts, aggression, fatigue, dizziness, instability, headaches, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, confusion, ringing in the ears, tingling or, in rare cases, electric shock sensations, weakness, sweating, convulsions or symptoms similar to the flu, vision problems and increased blood pressure (which can cause headaches, dizziness, ringing in the ears, sweating, etc.).
Your doctor will advise you on how to gradually stop treatment with Vandral Retard. This may take several weeks or months. In some patients, the interruption may need to be produced very gradually over months or more. If you experience any of these or other symptoms that bother you, consult your doctor for advice.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If any of the following side effects occur, do not take more Vandral Retard.Inform your doctor immediately, or go to the nearest hospital emergency room:
Rare (may affect up to 1 in 100 people)
Uncommon (may affect up to 1 in 1,000 people)
In its most severe form, serotonin syndrome may resemble neuroleptic malignant syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle rigidity, confusion, increased muscle enzymes (determined by blood tests).
Unknown frequency (cannot be estimated from available data)
Other side effects that you should inform your doctor are (the frequency of these side effects are included in the list below "other side effects that may occur"):
Do not worry if you see white pellets or small granules in your stool after taking this medicine. Inside the Vandral Retard capsules, there are spheroids (small white pellets) that contain the active ingredient (venlafaxine). These spheroids are released from the capsule in the stomach. As they circulate through the stomach and intestines, venlafaxine is released slowly. The "skin" of the spheroid does not dissolve and is eliminated in the stool. Therefore, although you see spheroids in the stool, the dose of the medicine has been absorbed.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Uncommon (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Unknown frequency (cannot be estimated from available data)
Vandral Retard may sometimes cause unwanted effects that you may not be aware of, such as increased blood pressure or abnormal heartbeat; mild changes in liver enzyme levels, sodium, or cholesterol. Less frequently, Vandral Retard may reduce the function of platelets in the blood, leading to an increased risk of petechiae or bleeding. Therefore, your doctor may wish to perform occasional blood tests, particularly if you have been taking Vandral Retard for a long time.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
Do not store at a temperature above30°C.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment..
The active ingredient is venlafaxine.
Each prolonged-release capsule contains 84.85 mg of venlafaxine hydrochloride, equivalent to 75 mg of venlafaxine base.
The other components are:
Capule content:microcrystalline cellulose, ethylcellulose, hypromellose, talc.
Capule coating:gelatin, iron oxide red and yellow (E172), titanium dioxide (E171).
Capule printing ink:shellac, iron oxide red (E172), ammonium hydroxide, simethicone, propylene glycol.
Each prolonged-release capsule contains 169.7 mg of venlafaxine hydrochloride, equivalent to 150 mg of venlafaxine base.
The other components are:
Capule content:microcrystalline cellulose, ethylcellulose, hypromellose, talc.
Capule coating:gelatin, iron oxide red and yellow (E172), titanium dioxide (E171).
Capule printing ink:shellac, sodium hydroxide (see section 2), povidone, titanium dioxide (E171), propylene glycol.
Each prolonged-release capsule contains 254.52 mg of venlafaxine hydrochloride, equivalent to 225 mg of venlafaxine base.
The other components are:
Capule content:microcrystalline cellulose, ethylcellulose, hypromellose, talc.
Capule coating:gelatin, iron oxide black, red and yellow (E172), titanium dioxide (E171).
Capule printing ink:shellac, sodium hydroxide (see section 2), povidone, titanium dioxide (E171), propylene glycol.
Vandral Retard 75 mg is a hard (gelatin) prolonged-release capsule, opaque and orange, 19.4 mm x 6.91 mm, with a 'W' and the dose '75' printed in red.
Vandral Retard 75 mg is available in:
Blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100 hard capsules and clinical packs of 500 (10x50) and 1,000 (10x100) hard capsules or in HDPE bottles of 14, 20, 50, 100 hard capsules and clinical packs of 500 and 1,000 hard capsules.
Unit dose blister packs of 14, 28, 84 and 100 hard capsules.
Vandral Retard 150 mg is a hard (gelatin) prolonged-release capsule, opaque and orange, 23.5 mm x 7.65 mm, with a 'W' and the dose '150' printed in white.
Vandral Retard 150 mg is available in:
Blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100 hard capsules and clinical packs of 500 (10x50) and 1,000 (10x100) hard capsules or in HDPE bottles of 14, 20, 50, 100 hard capsules and clinical packs of 500 and 1,000 hard capsules.
Unit dose blister packs of 14, 28, 84 and 100 hard capsules.
Vandral Retard 225 mg is an opaque capsule with a greyish-white coating and a dark orange body, with 'W' and '225' printed in white.
Vandral Retard 225 mg is available in:
Blister packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100 and clinical packs of 500 (10x50) and 1,000 (10x100).
Unit dose blister packs of 14, 28, 84 and 100 hard capsules.
Only some pack sizes may be marketed.
Marketing authorisation holder
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible person for manufacturing
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg Im Breisgau
Germany
or
Pfizer Ireland Pharmaceuticals
Little Connell
Newbridge
County Kildare
Ireland
Viatris Pharmaceuticals, S.L.U.
Calle General Aranaz, 86
28027 Madrid
Spain
Austria | Efectin ER 37.5mg Kapseln Efectin ER 75mg Kapseln Efectin ER 150mg Kapseln |
Bélgica, Luxemburgo | Efexor-Exel 37,5 Efexor-Exel 75 Efexor-Exel 150 Efexor-Exel 225 |
Bulgaria | Efectin ER 75mg Efectin ER 150mg |
República Checa | Efectin ER 37.5mg Efectin ER 75mg Efectin ER 150mg |
Chipre, Grecia, Estonia, Lituania, Portugal | Efexor XR |
Letonia | Efexor XR Efexor XR 75 Efexor XR 150 |
Dinamarca, Finlandia, Islandia, Noruega, Suecia | Efexor Depot |
Francia | Effexor L.P. |
Alemania | Trevilor retard 37,5mg Trevilor retard 75mg Trevilor retard 150mg |
Irlanda, Malta, Reino Unido(Irlanda del Norte) | Efexor XL |
Paises Bajos | Efexor XR 37,5 Efexor XR 75 Efexor XR 150 |
Italia | Efexor Faxine |
Polonia | Efectin ER 37,5 Efectin ER 75 Efectin ER 150 |
Rumanía | Efectin EP 37.5mg Efectin EP 75mg Efectin EP 150mg |
Eslovenia | Efectin ER 37,5mg trde kapsule s podaljšanim sprošcanjem Efectin ER 75mg trde kapsule s podaljšanim sprošcanjem Efectin ER 150mg trde kapsule s podaljšanim sprošcanjem |
España | Vandral Retard 75mghard capsules with prolonged release Vandral Retard 150mghard capsules with prolonged release Vandral Retard 225 mg hard capsules with prolonged release |
*[Please note that not all products and concentrations listed may be marketed].
Last update of this leaflet: July 2023
For detailed and updated information about this medicinal product, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.